The Incidence of Prostate Adenocarcinoma in Patients Who Underwent Cystoprostatectomy for Invasive Baldder Cancer and Histopathological Examination
Journal Title: Üroonkoloji Bülteni - Year 2016, Vol 15, Issue 2
Abstract
Objective: It was aimed to evaluate the incidence of prostate adenocarcinoma in patients treated by cystoprostatectomy for invasive bladder urothelial carcinoma and to demonstrate the histopathological features of prostate cancer cases. Materials and Methods: Between January 2010 and April 2015, totally 119 invasive bladder urothelial carcinoma patients operated by cystoprostatectomy without the diagnosis of prostate adenocarcinoma preoperatively were included into the study. The pathological records of patients were analyzed retrospectively. The patients were classified according to TNM system. Results: Prostate adenocarcinoma was detected in cystoprostatectomy materials of 16 patients (13.4%) and only 4 of the patients (25%) had clinically substantial prostate cancer. The average age was 62,3 (43-78, range) years. The pathological results of bladder urothelial carcinoma revealed as T2a in 4 (25%) patients, T2b in 4 (25%) patients, T3a in 6 (37.5%) patients and T4 only in 2 (12.5%) patients. Lymph node metastasis was detected in 5 (31.2%) patients and carcinoma in situ was detected in 5 (31.2%) patients. The mean follow-up time was 27.1 (463) months. The Gleason score of prostate cancer was 3+3 in 12 (75%) patients, 3+4 in 2 (12.5%) patient, 4+4 in 1 (6.25%) patient and 4+5 in 1 (6.25%) patient. The stages of prostate cancer were T2a in 14 (87.5%) patients, T2b in 1 (6.25%) patient and T3a in 1 (6.25%) patient. Conclusion: Life expectancy of the patients who had radical cystoprostatectomy due to invasive bladder tumor was affected dramatically by the pathological stage of urothelial carcinoma. Therefore, prostate-sparing radical cystectomy techniques can be used as alternative surgical methods for younger and chosen patients to minimize continence and erectile problems and to improve the quality of life.
Authors and Affiliations
Yasin Ceylan, Volkan Şen, Salih Polat, Bülent Günlüsoy, Tansu Değirmenci, Yusuf Kadir Topçu, Deniz Bolat, Zafer Kozacıoğlu
The Clinical, Oncological, Functional and Surgical Outcomes of Patients Who Underwent Adrenalectomy
Objective: Adrenal masses are often benign and rarely malignant. They may be also hormonally functional or non-functional. It is possible to treat these masses curatively with open and laparoscopic adrenalectomy. The aim...
Immunohistochemical Study of Cyclooxygenase-2 Expression in Prostate Carcinoma: It’s Relation with Apoptosis and Angiogenesis
Objective: Prostate carcinoma (PC) is one of the most commonly diagnosed cancer types with significant rates of mortality and morbidity. The etiology of PC is not clear. Cytokine and mediators at the inflammatory pathway...
Relationship Between Human Papilloma Virus and Bladder Cancer
Human papilloma virus (HPV) is a DNA virus with more than 170 types. HPV is the most common sexually transmitted infection and 10% of the world’s cancer burden is thought to be HPV infection-related. It is known that pre...
Predictive Value of Hormonal Evaluation Before Prostate Needle Biopsy on Prostate Cancer T Stage and Prognosis
Objective: In this study we evaluated the hormone data before prostate needle biopsy (PNB) in patients who underwent retropubic radical prostatectomy (RRP) due to prostate adenocarcinoma (PCa). Correlations between the p...
Neutropenic Fever, Skin and Eye Toxicities Develops During Docetaxel Treatment in Metastatic Prostate Cancer: A Case Report
Prostate cancer is one of the most common tumors in men. Docetaxel and prednisone treatment are accepted as standard therapy in castration-resistant prostate cancer patients. Docetaxel is a chemotherapeutic drug of the t...